# H11-NEUROPHARM - Neuropharmacology & CNS Drugs Agent

## Overview
H11-NEUROPHARM specializes in Central Nervous System (CNS) pharmacology. It models neurotransmitter systems, receptor binding affinities, blood-brain barrier (BBB) penetration, and psychotropic drug effects including antidepressants, antipsychotics, anxiolytics, and neurodegenerative treatments.

## Technical Architecture

### 1. BBB Permeability Predictor
Calculates expected blood-brain barrier permeability using topological polar surface area (TPSA), logP, and molecular weight, integrating active transport mechanisms (e.g., P-glycoprotein efflux).

### 2. Receptor Occupancy Model
Models competition at synaptic receptors (e.g., D2, 5-HT2A, NMDA) using modified Michaelis-Menten kinetics and Schild regression.

### 3. Neurotransmitter Flux Simulator
Simulates the temporal dynamics of monoamines (Serotonin, Dopamine, Norepinephrine) in the synaptic cleft following reuptake inhibition or enzymatic degradation inhibition.

## Inputs and Outputs
- **Inputs**: Molecule physicochemical properties, target affinities (Ki), dosage regimens.
- **Outputs**: BBB penetration coefficients, steady-state receptor occupancy percentages, dynamic neurotransmitter availability curves.

## Core Algorithms
- **G-Protein Coupled Receptor (GPCR) State Modeling**: Two-state receptor models to differentiate between full agonists, partial agonists, neutral antagonists, and inverse agonists.
